Stereoselective Crystallization of Chiral Pharmaceuticals Aided by Cellulose Derivatives through Helical Pattern Matching

Stereoselective inhibition aided by “tailor‐made” polymeric additives is an efficient approach to obtain enantiopure compounds through conglomerate crystallization. The chemical and configurational match between the side groups of polymers and the molecules of undesired enantiomer is considered to be a necessary condition for successful stereoseparation. Whereas in this contribution, we present an effective resolution of chiral pharmaceuticals by using cellulose acetates as the additives, which stereoselectively reside on the specific crystal faces of one enantiomer and inhibit its crystal nucleation and growth through helical pattern and supramolecular interaction complementarity. An investigation of nimodipine serves as a case study to highlight the novelty of this strategy wherein R‐crystals exhibiting an impressive enantiomeric excess value of 97 % can be attained by employing a mere 0.01 wt % cellulose acetate. Guaifenesin and phenyl lactic acid are also well‐resolved by utilizing this methodology. Our work not only brings about a brand‐new design strategy for “tailor‐made” additives, but will also promote the further exploration of the endless potential for utilizing natural biomolecules in chiral recognition and resolution. A novel design principle of helical pattern matching between the polymeric additives and the crystal surfaces are proposed for the stereoselective crystallization of chiral pharmaceuticals. A novel design principle of helical pattern matching between polymeric additives and crystal surfaces is proposed for the stereoselective crystallization of chiral pharmaceuticals. This method, demonstrated with nimodipine, guaifenesin, and phenyl lactic acid, achieves high enantiomeric purity, highlighting a new strategy for using natural biomolecules in chiral recognition and resolution.